期刊文献+

超声心动图在评价轻链型淀粉样变右心功能中的价值

Value of assessing right ventricular function by echocardiography in primary light-chain amyloidosis
下载PDF
导出
摘要 目的 初步探讨超声心动图在评价原发性轻链型心脏淀粉样变[(light-chain amyloidosis,AL)-(cardiac amyloidosis,CA)]患者右心功能的价值。方法 选取2018年1月至2021年12月在温州医科大学附属第一医院经病理检查确诊的AL-CA患者25例纳入淀粉样变组;另选取25名健康志愿者纳入对照组。经胸常规超声测量右心结构及功能指标;二维斑点追踪技术分析右心室整体长轴应变(right ventricular global longitudinal strain,RVGLS)和右心室游离壁长轴应变(right ventricular free wall longitudinal strain,RVfw LS);并计算三尖瓣环平面收缩期位移(tricuspid annular plane systolic excursion,TAPSE)/肺动脉收缩压(pulmonary artery systolic pressure,PASP)、RVGLS/PASP、RVfw LS/PASP作为无创的右室-肺动脉偶联指标。结果 (1)与对照组比较,淀粉样变组患者的右心明显增大,右室游离壁明显增厚[(7.16±1.84)mm vs.(3.76±0.66)mm],差异有统计学意义(P<0.001)。(2)与对照组比较,淀粉样变组患者的RVGLS[(17.43±2.45)%vs.(23.22±3.73)%]、RVfw LS [(18.44±2.10)%vs.(22.62±3.64)%]均显著降低,差异有统计学意义(P<0.001);淀粉样变组表现右心系统失偶联,TAPSE/PASP、RVGLS/PASP、RVfw LS/PASP均明显减低,差异有统计学意义(P<0.001)。(3)相关分析结果显示,TAPSE/PASP与N端脑钠肽前体(N-terminal brain natriuretic peptide precursor,NT-pro BNP)、高敏感肌钙蛋白(highly sensitive T cardiac troponin,hs-TNT)呈轻度相关(r=0.45、0.40),有统计学意义(P<0.05)。结论超声心动图能有效评估AL-CA患者右心功能损害情况,可为深入了解该疾病的病理生理学机制提供有价值的信息。 Objective To investigate the value of echocardiography in assessing right ventricular function of primary light-chain amyloidosis(AL)-cardiac amyloidosis(CA)patients.Methods A total of 25 patients biopsy diagnosed as AL-CA,who were admitted to the First Affiliated Hospital of Wenzhou Medical University from January 2018 to December 2021,were enrolled in this study as amyloidosis group.And 25 heathy volunteers were set as control group.The routine right ventricular morphology and functional parameters were acquired by standard echocardiography.Right ventricular global longitudinal strain(RVGLS)and right ventricular free wall longitudinal strain(RVfwLS)were obtained by two-dimensional speckle tracking imagine.Tricuspid annular plane systolic excursion(TAPSE)/pulmonary artery systolic pressure(PASP),RVGLS/PASP,RVfwLS/PASP ratio were calculated as the noninvasively parameters of right ventricular-pulmonary artery coupling.Results①Compared with control group,patients in amyloidosis group showed significantly larger right heart size,and significantly thicker right ventricular free wall[(7.16±1.84)mm vs.(3.76±0.66)mm],the difference was statistically significant(P<0.001).②Compared with control group,RVGLS[(17.43±2.45)%vs.(23.22±3.73)%]and RVfwLS[(18.44±2.10)%vs.(22.62±3.64)%]were significantly impaired in amyloidosis group,the difference was statistically significant(P<0.001).The ratios of TAPSE/PASP,RVGLS/PASP,RVfwLS/PASP were found to be lower in amyloidosis group,the difference was statistically significant(P<0.001).③TAPSE/PASP showed mild correlations with N-terminal brain natriuretic peptide precursor(NT-proBNP),highly sensitive T cardiac troponin(hs-TNT)(r=0.45 and 0.40)there were statistically significant(P<0.05).Conclusion Echocardiography can effectively evaluate the right heart function impairment in AL-CA patients,providing valuable information for a deeper understanding of the pathological and physiological mechanisms of the disease.
作者 廖书生 蒋一涵 叶腾 屠鸿翔 贾志军 LIAO Shusheng;JIANG Yihan;YE Teng;TU Hongxiang;JIA Zhijun(Department of Ultrasound,the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325000,Zhejiang,China;Laboratory Medicine Center,the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325000,Zhejiang,China)
出处 《中国现代医生》 2023年第36期49-53,共5页 China Modern Doctor
基金 温州市基础性医疗卫生科技项目(Y20211050)。
关键词 右心室 心肌淀粉样变 超声心动图 右室-肺动脉偶联 Right ventricle Cardiac amyloidosis Echocardiography Right ventricle arterial coupling
  • 相关文献

二级参考文献24

  • 1Gillmore JD, Wechalekar A, Bird J, et al. Guidelines on the diagnosis and investigation of AL amyloidosis [J]. Br J Haematol, 2015, 168(2): 207-218.
  • 2Gertz MA. Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment [J]. Am J Hematol, 2014, 89(12): 1132-1140.
  • 3Comenzo RL, Reece D, Palladini G, et al. Consensus guidelines for the conduct and reporting of clinical trials in systemic light- chain amyloidosis [J]. Leukemia, 2012, 26 (11): 2317-2325.
  • 4Dispenzieri A, Kyle R, Merlini G, et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders [J]. Leukemia, 2009, 23(2): 215-224.
  • 5Leung N, Nasr SH, Sethi S. How 1 treat amyloidosis: the impor- tance of accurate diagnosis and amyloid typing [ J]. Blood, 2012, 120( 16): 3206-3213.
  • 6Dispenzieri A, Gertz MA, Kyle RA, et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis [J]. J Clin Oncol, 2004, 22( 18): 3751-3757.
  • 7Kumar S, Dispenzieri A, Lacy MQ, et al. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements [J]. J Clin Oncol, 2012, 30(9): 989-995.
  • 8Palladini G, Dispenzieri A, Gertz MA, et al. New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes [J]. J Clin Oncol, 2012, 30(36):4541-4549.
  • 9Leung N, Glavey SV, Kumar S, et al. A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision? [J]. Haematologica, 2013, 98 (6): 988-992.
  • 10Girnius S, Seldin DC, Cibeira MT, et al. New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dosemelphalan and autologous stem-cell transplantation [J]. J Clin Oncol, 2013, 31 (21): 2749-2750.

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部